Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer.

ABSTRACT:

SUBMITTER: Sun F 

PROVIDER: S-EPMC11730446 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature